
Steven G Coca, DO
Internal Medicine, Nephrology
About Me
Steven G. Coca, DO, MS, is a Professor of Medicine at the Icahn School of Medicine at Mount Sinai, the Associate Chair for Clinical and Translational Research for the Department of Internal Medicine, and the Director of Clinical Research for the Division of Nephrology.
Dr. Coca’s research accomplishments are diverse and far-reaching: he has focused research efforts on short- and long-term outcomes of acute kidney injury, and assessing performance of biomarkers for rapid diagnosis and risk stratification in AKI. His research has advanced understanding of the clinical utility of prognostic, predictive, and efficacy biomarkers for CKD/diabetic kidney disease in several large cohort studies, including the ACCORD, VA NEPHRON-D, CANVAS, and DAPA-CKD clinical trials, as well as the Mount Sinai BioMe Biobank and the UPenn Medicine Biobank. He has been an active investigator in several large NIH consortia, including the TRIBE-AKI, ASSESS-AKI, CKD Biocon, and Kidney Precision Medicine Project (KPMP). Over the past 3 years, he has led collaborations to advance use of machine-learning techniques and multidimensional data acquisition to create risk-stratification tools for patients at risk or with prevalent chronic kidney disease, and studied the impact of exercise on longitudinal changes in the kidney. His work has led to the FDA approval and commercial implementation of the bioprognostic test, KidneyIntelX, a validated risk score for progression of CKD in adults with type 2 diabetes.
Since 2005, Dr. Coca has published numerous peer-reviewed research articles, reviews, and editorials, and has given numerous invited talks at national and international conferences and academic medical centers. He has engaged in multiple collaborative efforts in translational and clinical research, and served as a research mentor for many fellows, residents, medical students, and junior faculty members. He also serves on the editorial boards for the Journal of the American Society of Nephrology, the Clinical Journal of the American Society of Nephology, and Kidney International, and as an Associate Editor for Kidney360, and is a frequent reviewer on NIH study sections.
Dr. Coca received his D.O. degree from the University of New England College of Osteopathic Medicine, and completed his residency and nephrology fellowship at the Yale University School of Medicine. He received his Master of Science in Epidemiology and Public Health from the Yale University Graduate School of Arts and Sciences.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
About Me
Steven G. Coca, DO, MS, is a Professor of Medicine at the Icahn School of Medicine at Mount Sinai, the Associate Chair for Clinical and Translational Research for the Department of Internal Medicine, and the Director of Clinical Research for the Division of Nephrology.
Dr. Coca’s research accomplishments are diverse and far-reaching: he has focused research efforts on short- and long-term outcomes of acute kidney injury, and assessing performance of biomarkers for rapid diagnosis and risk stratification in AKI. His research has advanced understanding of the clinical utility of prognostic, predictive, and efficacy biomarkers for CKD/diabetic kidney disease in several large cohort studies, including the ACCORD, VA NEPHRON-D, CANVAS, and DAPA-CKD clinical trials, as well as the Mount Sinai BioMe Biobank and the UPenn Medicine Biobank. He has been an active investigator in several large NIH consortia, including the TRIBE-AKI, ASSESS-AKI, CKD Biocon, and Kidney Precision Medicine Project (KPMP). Over the past 3 years, he has led collaborations to advance use of machine-learning techniques and multidimensional data acquisition to create risk-stratification tools for patients at risk or with prevalent chronic kidney disease, and studied the impact of exercise on longitudinal changes in the kidney. His work has led to the FDA approval and commercial implementation of the bioprognostic test, KidneyIntelX, a validated risk score for progression of CKD in adults with type 2 diabetes.
Since 2005, Dr. Coca has published numerous peer-reviewed research articles, reviews, and editorials, and has given numerous invited talks at national and international conferences and academic medical centers. He has engaged in multiple collaborative efforts in translational and clinical research, and served as a research mentor for many fellows, residents, medical students, and junior faculty members. He also serves on the editorial boards for the Journal of the American Society of Nephrology, the Clinical Journal of the American Society of Nephology, and Kidney International, and as an Associate Editor for Kidney360, and is a frequent reviewer on NIH study sections.
Dr. Coca received his D.O. degree from the University of New England College of Osteopathic Medicine, and completed his residency and nephrology fellowship at the Yale University School of Medicine. He received his Master of Science in Epidemiology and Public Health from the Yale University Graduate School of Arts and Sciences.
Language
Position
Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
Clinical Focus
- Acute Renal Failure
- Acute Tubular Necrosis
- Chronic Renal Failure
- Dialysis
- Glomerulonephritis
- High Blood Pressure
- Hypertension (High Blood Pressure)
- Nephrotic Syndrome
Video
Education
DO, University of New England College of Osteopathic Medicine
MS, Yale University Graduate School of Arts and Sciences
Residency, Internal Medicine
Yale University School of Medicine
Fellowship, Nephrology
Yale University School of Medicine
Certifications
American Board of Internal Medicine
Awards
2021
ASN
Midcareer Distinguished Researcher Award
2021
Top Reviewer Award
American Journal of Nephrology
2019
MSIP
“Deal of the Year Award” (for RenalytixAI; shared with Drs. Murphy and Nadkarni)
2018
Stanley L. Cohen Memorial Lecture & Award
Yale New Haven/Bridgeport Hospital Foundation
2017
Joseph R. Renda Memorial Award
Yale University School of Medicine
2013
AFMR 2013 Junior Physician Investigator Award
American Federation for Medical Research
2013
Junior Physician Investigator Award
American Federation for Medical Research
2008
T. Franklin Williams Scholar
2008
K23 Career Development Award
NIH/NIDDK
2008
NIH Loan Repayment Program
NIH
2008
ASN
ASP Junior Development Grant in Geriatric Nephrology
2007
Henry Christian Award
American Federation for Medical Research
2002
Intern of the Year
Yale Primary Care Internal Medicine Program
Midcareer Distinguished Researcher Award,
American Society of Nephrology
Top 5 Reviewer of the Year
Journal of the American Society of Nephrology
Top 5 Reviewer of the Year
Clinical Journal of the American Society of Nephrology
MSIP “Deal of the Year Award”
(for RenalytixAI; shared with Drs. Murphy and Nadkarni)
Top 5 Reviewer of the Year,
Journal of the American Society of Nephrology
Top 5 Reviewer of the Year,
Clinical Journal of the American Society of Nephrology
4D Technology Development Program Award
SINAInnovations
Henry Christian Award
American Federation for Medical Research
Research
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Biomarker Panels for Predicting Progression of Kidney Disease in Acute Kidney Injury Survivors. Steven Menez, Kathleen F. Kerr, Si Cheng, David Hu, Heather Thiessen-Philbrook, Dennis G. Moledina, Sherry G. Mansour, Alan S. Go, T. Alp Ikizler, James S. Kaufman, Paul L. Kimmel, Jonathan Himmelfarb, Steven G. Coca, Chirag R. Parikh. Clinical Journal of the American Society of Nephrology
- Standardized Definitions of Changes in Kidney Function in Trials of Heart Failure: JACC Expert Panel From the HF-ARC. Anuradha Lala, Steven Coca, Jason Feinman, Carine E. Hamo, Mona Fiuzat, William T. Abraham, Christopher O'Connor, Jo Ann Lindenfeld, James Januzzi, Isabella Cavagna, John R. Teerlink, Mark J. Sarnak, Chirag R. Parikh, Wendy McCallum, Marvin A. Konstam, Maria Rosa Costanzo. Journal of the American College of Cardiology
- Biomarker Panels for Discriminating Risk of CKD Progression in Children. Jason H. Greenberg, Alison G. Abraham, Yunwen Xu, Jeffrey R. Schelling, Steven G. Coca, Sarah J. Schrauben, F. Perry Wilson, Sushrut S. Waikar, Ramachandran S. Vasan, Orlando M. Gutierrez, Michael G. Shlipak, Joachim H. Ix, Bradley A. Warady, Paul L. Kimmel, Joseph V. Bonventre, Chirag R. Parikh, Michelle Denburg, Susan Furth. Journal of the American Society of Nephrology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Coca during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- Renalytix AI, Inc
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Coca during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Founder/Co-Founder/Partner
- Renalytix AI, Inc
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.